Clincosm LogoSign in Get a demo

fallopian tube carcinoma

Showing 1 - 25 of 40
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Epithelial Carcinoma, Fallopian Tube Carcinoma, Peritoneal Carcinoma Trial in Sacramento (AHCC, Chemotherapy, Placebo)

Not yet recruiting
  • Ovarian Epithelial Carcinoma
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Feb 27, 2023

Ovarian Cancer, Fallopian Tube Carcinoma, Peritoneal Carcinoma Trial in Italy (carboplatin and paclitaxel followed by surgery)

Active, not recruiting
  • Ovarian Cancer
  • +2 more
  • carboplatin and paclitaxel followed by surgery
  • Bologna, Italy
  • +4 more
Dec 28, 2022

Germline Variant Carriers With BRCA1 or BRCA2

Recruiting
  • BRCA1 and/or BRCA2 Variant Carriers
  • +3 more
    • Okayama, Japan
      Okayama University
    Dec 25, 2022

    Advanced Malignant Solid Tumor, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +28 more
    • Conroe, Texas
    • +4 more
    Dec 5, 2022

    Melanoma, Breast Carcinoma, Hepatocellular Carcinoma Trial in United States (XmAb20717)

    Completed
    • Melanoma
    • +27 more
    • XmAb20717
    • Los Angeles, California
    • +16 more
    Nov 29, 2022

    ResiduAl Cancer With Liquid Biopsy Evaluation

    Recruiting
    • Bladder Carcinoma
    • +14 more
    • Guardant Reveal
    • Redwood City, California
      Redwood City
    Sep 7, 2022

    Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Epithelial Ovarian Cancer Trial in Baltimore (procedure, drug, other)

    Recruiting
    • Stage III Ovarian Cancer
    • +6 more
    • Cytoreductive Surgery (CRS)
    • +6 more
    • Baltimore, Maryland
      Mercy Medical Center
    Aug 30, 2022

    Breast Carcinoma, Fallopian Tube Carcinoma, Ovarian Carcinoma Trial in Houston (Computed Tomography, Fludeoxyglucose F-18,

    Recruiting
    • Breast Carcinoma
    • +7 more
    • Computed Tomography
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 24, 2022

    Factors Influencing Cascade Testing Among Hereditary

    Recruiting
    • Breast Carcinoma
    • +8 more
    • Interview
    • +2 more
    • Birmingham, Alabama
    • +1 more
    Jun 22, 2022

    FIGO Stage III Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Carcinoma Trial in Amsterdam (Cisplatin 100 mg/m2, Cisplatin 40

    Not yet recruiting
    • FIGO Stage III Ovarian Cancer
    • +2 more
    • Cisplatin 100 mg/m2
    • Cisplatin 40 mg/l
    • Amsterdam, Netherlands
      Antoni van Leeuwenhoek (NKI-AVL)
    Jun 3, 2022

    Stage III Ovarian Carcinoma, Stage IV Ovarian Carcinoma, Fallopian Tube Carcinoma Trial in United States (AVOVA-1, MC)

    Active, not recruiting
    • Stage III Ovarian Carcinoma
    • +3 more
    • AVOVA-1
    • MC
    • Burbank, California
    • +5 more
    Apr 21, 2022

    Fallopian Tube Carcinoma, Recurrent Ovarian Cancer, Primary Peritoneal Carcinoma Trial in Columbus (Lenvatinib Mesylate,

    Completed
    • Fallopian Tube Carcinoma
    • +3 more
    • Lenvatinib Mesylate
    • +2 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Apr 5, 2022

    Complications in Older Gynecologic Cancer Undergoing Surgery

    Completed
    • Endometrial Serous Adenocarcinoma
    • +9 more
    • Comprehensive Geriatric Assessment
    • Questionnaire Administration
    • Birmingham, Alabama
    • +392 more
    Nov 23, 2021

    Fallopian Tube Carcinoma, Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma Trial in United States

    Completed
    • Fallopian Tube Carcinoma
    • +37 more
    • Bevacizumab
    • +5 more
    • Birmingham, Alabama
    • +22 more
    Oct 19, 2021

    Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Stage I Ovarian Cancer Trial in Buffalo (procedure, drug, other)

    Completed
    • Fallopian Tube Carcinoma
    • +14 more
    • Diagnostic Microscopy
    • +2 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Oct 5, 2021

    Fallopian Tube Carcinoma, Ovarian Carcinoma, Primary Peritoneal Carcinoma Trial in Buffalo (biological, drug, other)

    Completed
    • Fallopian Tube Carcinoma
    • +2 more
    • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
    • +4 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Jul 20, 2021

    Epithelial Ovarian Carcinoma, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma Trial in Beijing (DCVAC/OvCa, Placebo)

    Recruiting
    • Epithelial Ovarian Carcinoma
    • +2 more
    • DCVAC/OvCa
    • Placebo
    • Beijing, Beijing, China
      Peking University Third Hospital
    Apr 30, 2021

    Primary Peritoneal Carcinoma, Ovarian Carcinoma, Fallopian Tube Carcinoma Trial in Lexington (neoadjuvant chemo)

    Completed
    Has Results
    • Primary Peritoneal Carcinoma
    • +2 more
    • neoadjuvant chemotherapy
    • Lexington, Kentucky
      University of Kentucky Markey Cancer Center
    Nov 17, 2020

    Cancer in Women at Increased Genetic Risk of Ovarian Cancer

    Completed
    • Breast Carcinoma
    • +3 more
    • Evaluation of Cancer Risk Factors
    • +3 more
    • Birmingham, Alabama
    • +140 more
    Aug 31, 2020

    FIGO Stage IIC-IV Ovarian Carcinoma, Fallopian Tube Carcinoma, Peritoneal Carcinoma Trial in Orange (carboplatin)

    Completed
    • FIGO Stage IIC-IV Ovarian Carcinoma
    • +2 more
    • Orange, California
      Chao Family Comprehensive Cancer Center
    Jan 29, 2020

    Fallopian Tube Carcinoma, Ovarian Carcinoma Trial in Palo Alto (Photoacoustic Imaging)

    Withdrawn
    • Fallopian Tube Carcinoma
    • Ovarian Carcinoma
    • Photoacoustic Imaging
    • Palo Alto, California
      Stanford University, School of Medicine
    Nov 26, 2018

    Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor Trial in

    Completed
    Has Results
    • Fallopian Tube Carcinoma
    • +7 more
    • Hamilton, Ontario, Canada
    • +3 more
    Jul 20, 2018

    Previously Untreated Invasive Ovarian Epithelial, Fallopian

    Completed
    • Fallopian Tube Carcinoma
    • +2 more
    • Laboratory Biomarker Analysis
    • Hinsdale, Illinois
    • +8 more
    May 21, 2018

    Epithelial Ovarian Cancer, Extraovarian Peritoneal Cancer, Fallopian Tube Carcinoma Trial in San Antonio (Denileukin Diftitox/SC

    Terminated
    Has Results
    • Epithelial Ovarian Cancer
    • +2 more
    • Denileukin Diftitox/SC Pegylated IFNα-2a
    • San Antonio, Texas
      CTRC (Cancer Therapy and Research Center) at UTHSCSA
    Mar 13, 2018

    Epithelial Ovarian Cancer, Extraovarian Peritoneal Cancer, Fallopian Tube Carcinoma Trial in San Antonio (Ontak)

    Completed
    Has Results
    • Epithelial Ovarian Cancer
    • +2 more
    • San Antonio, Texas
      CTRC at UTHSCSA
    Feb 27, 2018